Inovio Pharmaceuticals Stock Forecast

INO's stock price has decreased by -50.69% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 5 analysts polled by S&P Global, Inovio Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $5.86. The average 1-year stock price forecast is 447.66% higher than the current stock price, while the lowest is $1.80 (+68.22%) and the highest is $13 (+1,114.95%).

Price Target: $5.86 (+447.66%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.80	$5.86	$6.00	$13
Change	+68.22%	+447.66%	+460.75%	+1115.0%

Analyst Ratings

The average analyst rating for Inovio Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	2	2	2	2	2	2
Buy	2	2	2	2	1	1
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ram Selvaraju H.C. Wainwright	H.C. Wainwright	Hold Reiterates $2.5	Hold	Reiterates	$2.5	+133.64%	Jun 1, 2026
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Reiterates $6	Buy	Reiterates	$6	+460.75%	May 22, 2026

Financial Forecast

Revenue This Year

8.70M

from 65.34K

13,221.40%

from 65.34K

Revenue Next Year

61.92M

from 8.70M

611.34%

from 8.70M

EPS This Year

-1.09

from -1.82

EPS Next Year

-0.48

from -1.09

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.77M	10.26M	832.01K	217.76K	65.34K	8.70M
Revenue Growth	-76.05%	478.24%	-91.89%	-73.83%	-69.99%	13,221.40%
Gross Profit	-247.47M	-177.39M	-83.86M	-75.40M	-54.14M	6.53M
Gross Margin	-13,943.62%	-1,728.55%	-10,079.22%	-34,627.10%	-82,857.43%	75.00%
Operating Income	-301.22M	-253.57M	-126.74M	-112.40M	-86.82M	-70.43M
Net Income	-303.66M	-279.82M	-135.12M	-107.25M	-84.95M	-68.66M
EPS	-	-	-	-	-1.82	-1.09
Free Cash Flow	-123.41M	-115.43M	-81.97M	-47.59M	-38.68M	-57.00M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	41.5M
Avg	8.7M
Low	n/a

Revenue Growth

Revenue Growth	2026	2027	2028
High	63,446.2%
Avg	13,221.4%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-0.99
Avg	-1.09
Low	-1.27

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-